VerifyNow to Optimise Platelet Inhibition in Coronary Acute Syndrome

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 637 participants.

Also called NCT04654052

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 637 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04654052
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Spain (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04654052. Randomized; no masking; primary purpose treatment. Start 2021-07-02 (actual); primary completion 2026-07-29 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
VerifyNow to Optimise Platelet Inhibition in Coronary Acute Syndrome
Acronym
VERONICA
Condition
Acute Coronary Syndrome
Condition
Acute Myocardial Infarction
Intervention (Drug)
Clopidogrel
Intervention (Drug)
Previous treatment
Lead sponsor
Fundación EPIC (class: other)

Record details

Record id
cardio:ct-nct04654052
Content hash
a7c16070e818014b974f8470b204c39a2c079dde0407bcc8cd637a6d99a84e8b